Candonilimab
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody (NCT05994001) | Shanghai Zhongshan Hospital | 2023-08-01 |
Track Candonilimab automatically
Every clearance here is in the API, with alerts when new ones post.